August 27, 2016 12:45 AM ET

Life Sciences Tools and Services

Company Overview of Albany Molecular Research Inc.

Executive Profile

William S. Marth

Chief Executive Officer, President and Director, Albany Molecular Research Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 8 different industries.

See Board Relationships
61$1,639,417
As of Fiscal Year 2015

Background

Mr. William S. Marth, also known as Bill, has been the Chief Executive Officer and President of Albany Molecular Research Inc. since January 01, 2014. Mr. Marth served as the Chief Executive Officer and President of Americas for Teva Pharmaceutical Industries Limited from June 2010 to November 5, 2012, and served as its Senior Advisor until December 31, 2013. He served as the Chief Executive Officer and President of TEVA Pharmaceuticals USA, Inc., a division of Teva ...

Corporate Headquarters

26 Corporate Circle
Albany, New York 12203

United States

Phone: 518-512-2000
Fax: 518-512-2020

Board Members Memberships

2006-Present
Director
2012-Present
Chief Executive Officer, President and Director
2014-Present
Chairman, Chairman of Corporate Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee
2014-Present
Director and Member of Research & Development Committee

Education

BS 1977
University of Illinois-Urbana-Champaign
MBA 1989
Keller Graduate School of Management

Other Affiliations

Annual Compensation

Salary$650,000
Total Annual Compensation$650,000

Stocks Options

Restricted Stock Awards$760,703
All Other Compensation$17,464
Exercised Options$22,367
Exercised Options Value$306,430
Total Value of Options$306,430
Total Number of Options$22,367

Total Compensation

Total Annual Cash Compensation$878,714
Total Short Term Compensation$650,000
Other Long Term Compensation$778,167
Total Calculated Compensation$1,639,417
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James C. Mullen Chief Executive Officer and Executive Director
Patheon Holdings Coöperatief U.A.
$900.0K
Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation
$591.7K
Rudolf Hanko Ph.D.Chief Executive Officer
Siegfried Holding AG
$923.8K
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Pricing Committee and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.4M
Dayanand Thandalam Sriram Managing Director, Director, Member of Nomination & Remuneration Committee, Member of Risk Management & Corporate Governance Monitoring Committee, Member of Finance Committee and Member of Administrative Committee
GlaxoSmithKline Consumer Nigeria Plc
--
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Albany Molecular Research Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.